Satyanarayana Valiveti

发表

Transdermal delivery of naltrexone and its active metabolite 6-beta-naltrexol in human skin in vitro and guinea pigs in vivo.

P. Crooks, A. Stinchcomb, K. Paudel, 2005, Journal of pharmaceutical sciences.

Investigation of drug partition property in artificial sebum.

James A. Wesley, Satyanarayana Valiveti, G. Lu, 2008, International journal of pharmaceutics.

Intranasal Delivery of Recombinant Human Parathyroid Hormone [hPTH (1–34)], Teriparatide in Rats

D. Wermeling, A. Stinchcomb, P. Hayden, 2004, Endocrine research.

Permeation of WIN 55,212‐2, a potent cannabinoid receptor agonist, across human tracheo‐bronchial tissue in vitro and rat nasal epithelium in vivo

A. Stinchcomb, K. Paudel, P. Hayden, 2006, The Journal of pharmacy and pharmacology.

In Vitro/in Vivo Correlation of Transdermal Naltrexone Prodrugs in Hairless Guinea Pigs

P. Crooks, A. Stinchcomb, K. Paudel, 2005, Pharmaceutical Research.

Targeting the Pilosebaceous Gland

J. Grice, S. E. Cross, S. Ciotti, 2008 .

Cannabidiol bioavailability after nasal and transdermal application: effect of permeation enhancers

A. Stinchcomb, K. Paudel, D. Hammell, 2010, Drug development and industrial pharmacy.

Comparison of artificial sebum with human and hamster sebum samples.

Lora C Robosky, Matthew J. Mollan, Julie K. Spence, 2009, International journal of pharmaceutics.

Transdermal Delivery of the Synthetic Cannabinoid WIN 55,212-2: In Vitro/in Vivo Correlation

A. Stinchcomb, D. Hammell, Satyanarayana Valiveti, 2004, Pharmaceutical Research.

Transdermal permeation of WIN 55,212-2 and CP 55,940 in human skin in vitro.

A. Stinchcomb, D. Hammell, P. Kiptoo, 2004, International journal of pharmaceutics.

In vitro/in vivo correlation studies for transdermal Δ8‐THC development

A. Stinchcomb, D. Hammell, Satyanarayana Valiveti, 2004 .

Human skin permeation of Δ8‐tetrahydrocannabinol, cannabidiol and cannabinol

D. R. Ramsey, A. Stinchcomb, D. Hammell, 2004 .

Enhanced bioavailability of danazol nanosuspensions by wet milling and high-pressure homogenization

Mita Patel, Y. Tseng, Naveen Kanthamneni, 2016, International journal of pharmaceutical investigation.

Diffusion properties of model compounds in artificial sebum.

Satyanarayana Valiveti, G. Lu, 2007, International journal of pharmaceutics.

Liquid chromatographic-mass spectrometric quantitation of Delta9-tetrahydrocannabinol and two metabolites in pharmacokinetic study plasma samples.

A. Stinchcomb, Satyanarayana Valiveti, 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

LC–MS method for the estimation of Δ8-THC and 11-nor-Δ8-THC-9-COOH in plasma

Satyanarayana Valiveti, Dana C. Hammell, D. Caroline Earles, 2005 .

LC-MS method for the estimation of delta8-THC and 11-nor-delta8-THC-9-COOH in plasma.

A. Stinchcomb, D. Hammell, Satyanarayana Valiveti, 2005, Journal of pharmaceutical and biomedical analysis.

Intranasal absorption of Δ9-tetrahydrocannabinol and WIN55,212-2 mesylate in rats

D. Wermeling, A. Stinchcomb, K. Paudel, 2007 .

Intranasal absorption of Delta(9)-tetrahydrocannabinol and WIN55,212-2 mesylate in rats.

D. Wermeling, A. Stinchcomb, K. Paudel, 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

In vivo evaluation of 3-O-alkyl ester transdermal prodrugs of naltrexone in hairless guinea pigs.

P. Crooks, A. Stinchcomb, K. Paudel, 2005, Journal of controlled release : official journal of the Controlled Release Society.

Development and validation of a liquid chromatography-mass spectrometry method for the quantitation of naltrexone and 6beta-naltrexol in guinea pig plasma.

A. Stinchcomb, K. Paudel, D. Hammell, 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Human skin permeation of Delta8-tetrahydrocannabinol, cannabidiol and cannabinol.

D. R. Ramsey, A. Stinchcomb, D. Hammell, 2004, The Journal of pharmacy and pharmacology.